745 related articles for article (PubMed ID: 30501599)
1. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
2. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans.
Guo N; Liu J; Wu X; Bi X; Meng R; Wang X; Xiang H; Deng X; Yu L
J Med Microbiol; 2009 Aug; 58(Pt 8):1074-1079. PubMed ID: 19528168
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
6. New Thiazolyl-triazole Schiff Bases: Synthesis and Evaluation of the Anti-Candida Potential.
Stana A; Enache A; Vodnar DC; Nastasă C; Benedec D; Ionuț I; Login C; Marc G; Oniga O; Tiperciuc B
Molecules; 2016 Nov; 21(11):. PubMed ID: 27879678
[TBL] [Abstract][Full Text] [Related]
7. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
[No Abstract] [Full Text] [Related]
8. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans.
Ahmad A; Wani MY; Khan A; Manzoor N; Molepo J
PLoS One; 2015; 10(12):e0145053. PubMed ID: 26694966
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
11. Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
Thamban Chandrika N; Shrestha SK; Ngo HX; Tsodikov OV; Howard KC; Garneau-Tsodikova S
J Med Chem; 2018 Jan; 61(1):158-173. PubMed ID: 29256601
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents.
Zhao S; Zhao L; Zhang X; Liu C; Hao C; Xie H; Sun B; Zhao D; Cheng M
Eur J Med Chem; 2016 Nov; 123():514-522. PubMed ID: 27494168
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Sun L; Liao K; Hang C
Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
[TBL] [Abstract][Full Text] [Related]
17. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
[TBL] [Abstract][Full Text] [Related]
18. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Lu Y; Zhou Z; Mo L; Guo Q; Peng X; Hu T; Zhou X; Ren B; Xu X
Appl Microbiol Biotechnol; 2019 Aug; 103(16):6701-6709. PubMed ID: 31201451
[TBL] [Abstract][Full Text] [Related]
19. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
Han B; Chen J; Yu YQ; Cao YB; Jiang YY
Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
